{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:01:42Z","timestamp":1777633302451,"version":"3.51.4"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala"},{"name":"Department of Biotechnology, New Delhi, India","award":["BT\/PR4548\/INF\/22\/ 146\/2012"],"award-info":[{"award-number":["BT\/PR4548\/INF\/22\/ 146\/2012"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["BIC\/11(02)\/2015"],"award-info":[{"award-number":["BIC\/11(02)\/2015"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.yebeh.2016.05.005","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T21:51:54Z","timestamp":1468533114000},"page":"248-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression"],"prefix":"10.1016","volume":"61","author":[{"given":"Tanveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh Kumar","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.yebeh.2016.05.005_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for anti-epileptic drug discovery and development","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2011.05.023","article-title":"Depression, stress, epilepsy and adult neurogenesis","volume":"233","author":"Danzer","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.expneurol.2014.09.004","article-title":"Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy","volume":"263","author":"Klein","year":"2015","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70018-8","article-title":"The neurobehavioural comorbidities of epilepsy: can a natural history be developed?","volume":"7","author":"Hermann","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0025","first-page":"809843","article-title":"Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations","volume":"2012","author":"Garcia","year":"2012","journal-title":"Epilepsy Res Treat"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2016.05.005_bb0035","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.yebeh.2016.05.005_bb0040","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/brain\/awn117","article-title":"Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine","volume":"131","author":"Mazarati","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0045","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1002\/phar.1549","article-title":"Breakthrough seizures after starting vilazodone for depression","volume":"35","author":"McKean","year":"2015","journal-title":"Pharmacother"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0050","article-title":"Antidepressants for people with epilepsy and depression","volume":"12","author":"Maguire","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.03.009","article-title":"Kindling and status epilepticus models of epilepsy: rewiring the brain","volume":"73","author":"Morimoto","year":"2004","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-4886(69)90128-9","article-title":"A permanent change in brain function resulting from daily electrical stimulation","volume":"25","author":"Goddard","year":"1969","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2008.05.002","article-title":"Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole-kindled rats","volume":"439","author":"Szyndler","year":"2008","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-0173(89)90003-9","article-title":"Animal models of the epilepsies","volume":"14","author":"Fisher","year":"1989","journal-title":"Brain Res Brain Res Rev"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2016.05.005_bb0075","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2008.11.010","article-title":"Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains","volume":"602","author":"Mason","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1528-1157.1994.tb02906.x","article-title":"Pentylenetetrazole-induced seizures decrease gamma-aminobutyric acid-mediated recurrent inhibition and enhance adenosine-mediated depression","volume":"35","author":"Psarropoulou","year":"1994","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0091-3057(91)90562-G","article-title":"Pentylenetetrazol induced kindling in rats: effect of GABA function inhibitors","volume":"40","author":"Corda","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2016.05.005_bb0090","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1528-1157.1984.tb03452.x","article-title":"Development and persistence of kindled seizures after repeated injections of pentylenetetrazol in rats and guinea pigs","volume":"25","author":"Diehl","year":"1984","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0387-7604(96)00492-5","article-title":"Regional excitatory and inhibitory amino acid concentrations in pentylenetetrazol kindling and kindled rat brain","volume":"19","author":"Sejima","year":"1997","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yebeh.2012.11.004","article-title":"Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice","volume":"27","author":"Singh","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yebeh.2014.10.002","article-title":"Ficus religiosa L. figs\u2014a potential herbal adjuvant to phenytoin for improved management of epilepsy and associated behavioral comorbidities","volume":"41","author":"Singh","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2016.05.005_bb0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.yebeh.2005.08.019","article-title":"Spatial learning deficits and emotional impairments in pentylenetetrazole-kindled rats","volume":"7","author":"Mortazavi","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yebeh.2007.02.001","article-title":"Kindling epileptogenesis in immature rats leads to persistent depressive behavior","volume":"10","author":"Mazarati","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pnpbp.2003.09.026","article-title":"Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice","volume":"28","author":"Hansen","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.yebeh.2016.05.005_bb0125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/187152707783220910","article-title":"Neurotransmitter regulation of adult neurogenesis: putative therapeutic targets","volume":"6","author":"Vaidya","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/brain\/awu339","article-title":"Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug","volume":"138","author":"Doeser","year":"2015","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.yebeh.2013.05.002","article-title":"Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures","volume":"28","author":"Russo","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2016.05.005_bb0140","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11011-015-9650-8","article-title":"Comparative behavioral and neurochemical analysis of phenytoin and valproate treatment on epilepsy induced learning and memory deficit: search for add on therapy","volume":"30","author":"Mishra","year":"2015","journal-title":"Metab Brain Dis"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0150","article-title":"The mouse forced swim test","volume":"59","author":"Can","year":"2012","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.11.001","article-title":"Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta","volume":"37","author":"Mazarati","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/endo-74-4-653","article-title":"Fluorometric determination of corticosterone and cortisol in 0.02\u20130.05milliliters of plasma or submilligram samples of adrenal tissue","volume":"74","author":"Glick","year":"1964","journal-title":"Endocrinology"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front Neurosci"},{"issue":"6","key":"10.1016\/j.yebeh.2016.05.005_bb0170","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2008.02.006","article-title":"Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action","volume":"54","author":"Smolders","year":"2008","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.yebeh.2016.05.005_bb0175","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/jcbfm.2013.54","article-title":"Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice","volume":"33","author":"Smeland","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"10.1016\/j.yebeh.2016.05.005_bb0180","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s11064-013-1163-4","article-title":"Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy","volume":"38","author":"Mishra","year":"2013","journal-title":"Neurochem Res"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0704s63","article-title":"Detection and quantification of neurotransmitters in dialysates","author":"Zapata","year":"2013","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0190","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4137\/IJTR.S6225","article-title":"Rapid isocratic liquid chromatographic separation and quantification of tryptophan and six kynurenine metabolites in biological samples with ultraviolet and fluorimetric detection","volume":"3","author":"Badawy","year":"2010","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0195","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jep.2015.09.025","article-title":"Pharmacological validation of in-silico guided novel nootropic potential of Achyranthes aspera L","volume":"175","author":"Gawande","year":"2015","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0200","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuroscience.2004.09.025","article-title":"Magnetic resonance and biochemical studies during pentylenetetrazole-kindling development: the relationship between nitric oxide, neuronal nitric oxide synthase and seizures","volume":"129","author":"Itoh","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2015.04.007","article-title":"Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity","volume":"49","author":"Singh","year":"2015","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yebeh.2005.06.003","article-title":"New facets of the neuropathology and molecular profile of human temporal lobe epilepsy","volume":"7","author":"de Lanerolle","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2015.06.013","article-title":"Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats","volume":"301","author":"Soukupova","year":"2015","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.yebeh.2016.05.005_bb0220","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2165\/11633130-000000000-00000","article-title":"Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date","volume":"72","author":"Mathews","year":"2012","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0230","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.nbd.2007.03.003","article-title":"Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy","volume":"26","author":"Pitsch","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.euroneuro.2006.03.002","article-title":"Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests","volume":"17","author":"Belozertseva","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0240","doi-asserted-by":"crossref","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","article-title":"Glutamatergic mechanisms associated with seizures and epilepsy","volume":"5","author":"Barker-Haliski","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.yebeh.2016.05.005_bb0245","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/hipo.22160","article-title":"Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis","volume":"23","author":"Kandratavicius","year":"2013","journal-title":"Hippocampus"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2012.09.013","article-title":"Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives","volume":"203","author":"Dorandeu","year":"2013","journal-title":"Chem Biol Interact"},{"issue":"6","key":"10.1016\/j.yebeh.2016.05.005_bb0255","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/cns.12096","article-title":"Treatment of status epilepticus with ketamine, are we there yet?","volume":"19","author":"Dorandeu","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus","volume":"30","author":"Fang","year":"2015","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2016.05.005_bb0265","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bcp.2015.03.011","article-title":"Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs","volume":"95","author":"Dale","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0275","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.1994.62031137.x","article-title":"Valproate increases glutaminase and decreases glutamine synthetase activities in primary cultures of rat brain astrocytes","volume":"62","author":"Collins","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neubiorev.2015.12.014","article-title":"GABA-ergic cell therapy for epilepsy: advances, limitations and challenges","volume":"62","author":"Shetty","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0285","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-3565(25)32552-8","article-title":"Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity","volume":"217","author":"Balding","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.yebeh.2016.05.005_bb0290","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10","article-title":"A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders","volume":"13","author":"Jobe","year":"1999","journal-title":"Crit Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-4886(86)90111-1","article-title":"Kindling antagonism: effects of norepinephrine depletion on kindled seizure suppression after concurrent, alternate stimulation in rats","volume":"94","author":"Applegate","year":"1986","journal-title":"Exp Neurol"},{"issue":"10","key":"10.1016\/j.yebeh.2016.05.005_bb0300","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0028-3908(88)90072-X","article-title":"Characteristics of accelerated kindling after depletion of noradrenaline in adult rats","volume":"27","author":"Corcoran","year":"1988","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0305","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp.43.1.68","article-title":"Platelet monoamine oxidase activity in epilepsy","volume":"43","author":"Kruk","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0310","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0920-1211(94)00069-9","article-title":"Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures","volume":"20","author":"Kumlien","year":"1995","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.yebeh.2016.05.005_bb0315","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2004.02355.x","article-title":"Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors","volume":"89","author":"Clinckers","year":"2004","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.yebeh.2016.05.005_bb0320","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","article-title":"Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study","volume":"59","author":"Biggs","year":"1992","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0197-0186(94)90130-9","article-title":"Sodium valproate induced alterations in monoamine levels in different regions of the rat brain","volume":"24","author":"Baf","year":"1994","journal-title":"Neurochem Int"},{"issue":"4","key":"10.1016\/j.yebeh.2016.05.005_bb0330","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9441-0","article-title":"Valproate disturbs the balance between branched and aromatic amino acids in rats","volume":"25","author":"Maciejak","year":"2014","journal-title":"Neurotox Res"},{"issue":"5","key":"10.1016\/j.yebeh.2016.05.005_bb0335","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1212\/01.WNL.0000049930.93113.20","article-title":"PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy","volume":"60","author":"Toczek","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0340","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1528-1167.2006.00458.x","article-title":"The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography","volume":"47","author":"Theodore","year":"2006","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2016.05.005_bb0345","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.biopsych.2007.02.015","article-title":"5-HT (1A) receptor binding in temporal lobe epilepsy patients with and without major depression","volume":"62","author":"Hasler","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yebeh.2009.07.031","article-title":"Upregulation of 5-HT2C receptors in hippocampus of pilocarpine-induced epileptic rats: antagonism by Bacopa monnieri","volume":"16","author":"Krishnakumar","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.yebeh.2016.05.005_bb0355","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/mp.2013.144","article-title":"Serotonin 2C receptor antagonists induce fast-onset antidepressant effects","volume":"19","author":"Opal","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.yebeh.2016.05.005_bb0360","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"issue":"23","key":"10.1016\/j.yebeh.2016.05.005_bb0365","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/13816128113196660734","article-title":"Serotonin 5-HT4 receptors: a new strategy for developing fast acting antidepressants?","volume":"20","author":"Vidal","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0370","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1073858414561303","article-title":"Serotonin 1A and serotonin 4 receptors: essential mediators of the neurogenic and behavioral actions of antidepressants","volume":"22","author":"Samuels","year":"2014","journal-title":"Neuroscientist"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0375","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00221-013-3757-0","article-title":"The role of different serotonin receptor subtypes in seizure susceptibility","volume":"232","author":"Gharedaghi","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0380","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fphar.2015.00046","article-title":"Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?","volume":"6","author":"Guiard","year":"2015","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.yebeh.2016.05.005_bb0385","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-011-0700-z","article-title":"The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures","volume":"119","author":"Szyndler","year":"2012","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0395","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.eplepsyres.2011.02.003","article-title":"Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy","volume":"94","author":"Liimatainen","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-11-41","article-title":"Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy","volume":"11","author":"Xie","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0405","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"287","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0410","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.12.015","article-title":"Minocycline does not evoke anxiolytic and antidepressant-like effects in C57BL\/6 mice","volume":"301","author":"Vogt","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0415","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fncel.2015.00005","article-title":"Minocycline treatment ameliorates interferon-alpha-induced neurogenic defects and depression-like behaviors in mice","volume":"9","author":"Zheng","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuroscience.2012.12.052","article-title":"The kynurenine pathway: a missing piece in the puzzle of valproate action?","volume":"234","author":"Maciejak","year":"2013","journal-title":"Neuroscience"},{"issue":"1\u20133","key":"10.1016\/j.yebeh.2016.05.005_bb0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2011.10.017","article-title":"Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants","volume":"673","author":"Takechi","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.yebeh.2016.05.005_bb0430","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1528-1167.2008.01850.x","article-title":"The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet","volume":"49","author":"Weinshenker","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0435","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","article-title":"The role of dopamine in epilepsy","volume":"22","author":"Starr","year":"1996","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0440","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.nbd.2009.02.018","article-title":"Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy","volume":"34","author":"Mazarati","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0445","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0166-2236(96)10069-2","article-title":"Neurocircuitry of stress: central control of the hypothalamo-pituitary\u2013adrenocortical axis","volume":"20","author":"Herman","year":"1997","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.yebeh.2016.05.005_bb0450","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.wnl.0000252813.86812.81","article-title":"Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy","volume":"68","author":"Gilliam","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2016.05.005_bb0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.niox.2011.02.002","article-title":"Nitric oxide and major depression","volume":"24","author":"Dhir","year":"2011","journal-title":"Nitric Oxide"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0460","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.neuroscience.2008.12.040","article-title":"Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase","volume":"159","author":"Itoh","year":"2009","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.yebeh.2016.05.005_bb0465","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12035-014-8669-x","article-title":"Neuropeptides as targets for the development of anticonvulsant drugs","volume":"50","author":"Clynen","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0470","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2015.04.031","article-title":"Comorbidities in neurology: is adenosine the common link?","volume":"97","author":"Boison","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2016.05.005_bb0475","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2015.10.034","article-title":"Morphine modulates the effects of histamine H1 and H3 receptors on seizure susceptibility in pentylenetetrazole-induced seizure model of mice","volume":"769","author":"Amini-Khoei","year":"2015","journal-title":"Eur J Pharmacol"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016300798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016300798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:12:56Z","timestamp":1748999576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505016300798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":95,"alternative-id":["S1525505016300798"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.05.005","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}